Enacts the manufacturer disclosure and transparency act
1
What it does
Official summary
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
2
Where do you stand?
Choose your position
3
Tell your reps
Take a position to see your representatives and ways to contact them.
4
More on this bill
Where it stands
Introduced
Passed 1st Chamber
Passed 2nd Chamber
4To Governor
5Became Law
Looking ahead
No hearings or votes scheduled.
History
2026
May 12REFERRED TO CONSUMER AFFAIRS AND PROTECTIONLatest
Vote recorded Floor Vote - Version: A. Result: pass.Upper
Vote recorded Rules Vote - Version: A. Result: pass.Upper
Vote recorded Finance Vote - Version: A. Result: pass.Upper
May 12DELIVERED TO ASSEMBLY
May 12PASSED SENATEMajor
May 12ORDERED TO THIRD READING CAL.1005
May 12REPORTED AND COMMITTED TO RULESMinor
May 11
Vote recorded Rules Vote - Version: A. Result: pass.Upper
Jan 28
Vote recorded Consumer Protection Vote - Version: A. Result: pass.Upper
Jan 7REFERRED TO CONSUMER PROTECTIONMinor
Jan 7RETURNED TO SENATE
Jan 7DIED IN ASSEMBLY
2025
Jun 9REFERRED TO CONSUMER AFFAIRS AND PROTECTIONMinor
Vote recorded Floor Vote - Version: A. Result: pass.Upper
Jun 9DELIVERED TO ASSEMBLY
Jun 9REPASSED SENATEPassed 2nd Chamber
May 22AMENDED ON THIRD READING 488AMajor
May 22VOTE RECONSIDERED - RESTORED TO THIRD READING
May 22RETURNED TO SENATE
May 22RECALLED FROM ASSEMBLY
Feb 25REFERRED TO CONSUMER AFFAIRS AND PROTECTIONMinor
Vote recorded Floor Vote. Result: pass.Upper
Feb 25DELIVERED TO ASSEMBLY
Feb 25PASSED SENATEPassed 1st Chamber
Feb 4ADVANCED TO THIRD READING
Feb 32ND REPORT CAL.
Jan 281ST REPORT CAL.204
Vote recorded Consumer Protection Vote. Result: pass.Upper